We describe the anaesthetic management of a patient requiring intra-operative MRI and awake neurological testing during neurosurgical resection of a frontal tumour. This tumour involved her motor and speech areas. The anaesthetic drugs administered during awake craniotomy should be safe and allow appropriate changes in the level of sedation, so that the patient is adequately sedated during periods of intense surgical stimulus, yet awake, comfortable and cooperative during functional testing and tumour resection. We report the novel and successful use of a sedative -dexmedetomidine in combination with a narcotic, remifentanil. There has not been much experience with this combination locally. Dexmedetomidine, a selective alpha-2 agonist with sedative, analgesic and anaesthetic-sparing effect does not suppress ventilation. Patients are sedated, but can be easily roused verbally. Remifentanil is a useful choice in this surgery as it can be rapidly titrated according to level of surgical intensity and has a reliable context sensitive half life. Potential problems associated with awake craniotomy such as impaired ventilation during sedation, nausea, vomiting and seizures are discussed. These anaesthetic challenges are compounded by the challenges posed by the iMRI environment. Emphasis is placed on patient selection and preparation peri-operatively. This is crucial to the success of the operation.
INTRODUCTION
Awake craniotomy for brain tumours is regularly performed in Singapore General Hospital (SGH). This is a surgical technique that allows surgeons to perform intra-operative electro-physiologic mapping (EPM) of the brain and continuous neurophysiological monitoring. These guide resection of tumours especially around eloquent areas of the brain, namely, parts that control speech, sensory and motor functions 1 .
Continuous neurological testing allows early detection of surgical encroachment of motor, sensory or language domains. Concurrent use of intra-operative high field magnetic resonance imaging (iMRI) allows superior image guidance which when combined with electro-physiologic mapping (EPM), facilitates safer and more extensive surgical resection 2 .
An intraoperative magnetic resonance imaging (iMRI) facility is available in SGH, and increasing numbers of awake craniotomy are being performed within this iMRI facility -a technique which is still not common elsewhere.
We describe the anaesthetic management of a patient needing intra-operative MRI scanning and awake neurological testing during resection of a frontal tumour involving her motor and speech areas. We highlight the novel and successful use of a combination of sedative -dexmedetomidine, and narcotic -remifentanil. This technique has not been reported in SGH, for awake craniotomy, and there has not been much experience with this combination locally.
These anaesthetic drugs allow rapid changes in the level of sedation and analgesia, in accordance with the course of the imaging, testing and surgery. We achieved our goals of keeping the patient adequately sedated during periods of intense surgical stimulus, yet awake, comfortable and cooperative during functional testing, tumour resection and MRI imaging.
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CASE REPORT
A 47-year old woman, weighing 50 kg and of 156 cm in height (BMI 20.5) presented for awake craniotomy and resection of recurrent left frontal oligodendroma which was previously resected in 2000. She recently experienced four months of simple partial seizures for which she was treated with carbamazepine and lamotrigine.
The patient had no co-morbidities and no contraindications to having surgery in an iMRI theatre. In particular, she was neither obese nor had any history of obstructive sleep apnoea (OSA). This is important because patients with OSA are very sensitive to sedatives, especially opioids 3 . Their airway tends to become obstructed under sedation and can result in carbon dioxide retention and hypoxemia. Hypercarbia and hypoxemia are detrimental during brain surgery because it results in increased cerebral blood flow and brain swelling.
Fortunately, this patient had no pre-operative neurological or cognitive deficits that preclude her cooperation during awake neurological testing. Furthermore, she was motivated and deemed emotionally suitable for such a procedure. A patient having hysteria or panic attack, in the middle of surgery, would be a difficult situation to manage.
Pre-operative imaging ( Fig. 1 ) did not demonstrate signs of raised intra-cranial pressure. Pre-operative functional MRI revealed that her right hand movement activation centre was located within one centimetre (cm) posterior to the brain lesion while a smaller area of adjacent activation was seen at the mid-portion of this lesion. Reading activation was located inferior and posterior to the lesion with small areas of intra-lesional activation. Elocution activation was noted to be anterior and just adjacent to the lesion.
As the lesion was sited very close to these eloquent areas of the patient's brain, she was deemed to benefit from awake intra-operative neurological assessment. She was counselled by the surgeons about the sequence of events during an awake craniotomy and the manner in which intra-operative neurological assessment would be conducted.
Prior to the start of the procedure, monitors including non-invasive blood pressure cuff, intra-arterial line, pulse oximeter, three-lead electrocardiogram, axillary skin temperature probe and an end-tidal carbon dioxide (CO 2 ) sampling line were sited. The patient received supplemental oxygen via face-mask with oxygen flow at 6 L/min. A urinary catheter was also inserted in anticipation of prolonged surgery. This minimised discomfort from a distended bladder since mannitol would be used intra-operatively. She was kept warm with a warming forced air blower (Bair Hugger). The timeline of intraoperative events aligned with drugs and dosages administered is presented in Fig. 2 .
RESULTS
The entire operation, inclusive of scan times, lasted six hours. About 90% of the tumour was resected ( Fig. 3) .
The patient was observed in Neurosurgical Intensive Care for a day followed by three days in the general ward and was discharged on post-operative day 4.
She was observed to have difficulty in expression on her first post-operative day, although she remained oriented to her location, time and people. She was assessed by speech therapist to have moderate expressive dysphasia. Though she had mild right sided upper limb and lower limb weakness; she was still able to move them against gravity but had delays in initiation of movement and experienced problems with fine motor coordination. These were deemed to be temporary, possibly from brain retraction and post-operative oedema of the brain. Her gait was assessed by the physiotherapist to be normal. Sensation was intact over her right side.
When assessed one month after her surgery, her speech was 60% of normal. Right arm and leg strength had returned to normal.
DISCUSSION
Awake craniotomy has numerous advantages when compared to craniotomy performed under general anaesthesia.
It allows the surgeon to delineate a functional map of the brain surface for motor and language functions through electro-cortical stimulation mapping, helping the surgeon to decide on the margin of resection of tumour around functional areas. A resection margin of more than 1 cm away from the nearest eloquent area has been shown to result in less language deficits, compared to resection right up to the edge of positive stimulation sites for tumours near speech areas 5, 6 .
Awake craniotomy also allows the surgeon to perform continuous neurophysiological assessment by engaging the patient in conversation for speech monitoring, and motor assessment by asking the patient to perform certain commands.
An intra-operative imaging facility such as MRI scanning also allows point-of-care imaging and hence more precise resection of tumour since image guidance using pre-operative imaging becomes less accurate when the brain shifts as the tumour is removed or if there is any intra-operative brain swelling. This is especially so in larger tumours or tumours adjacent to the ventricles 7 .
Sedation during awake craniotomy has to be skilfully titrated according to the intensity of surgical stimulus. Complications that can arise during awake craniotomy include hypoxaemia and hypercarbia due to impaired ventilation; nausea, vomiting, seizures, intracerebral bleeding and haemodynamic instability. Desaturation can occur when deeper sedation is required for certain stages of surgery such as scalp and bone work. The incidence of respiratory complication can be as high as 24% 8 . Some patients can be managed with simple jaw thrust; others require the insertion of airway adjuncts, cessation of sedation and even endotracheal intubation. Airway equipment has to be readily available and since this procedure was performed in iMRI, the airway equipment has to be MRI compatible. One has to be mindful that manoeuvres to the airway may affect sterility of the operating field [9] [10] [11] .
Airway devices such as the Guedel oropharyngeal airways and endotracheal tube (ETT) intubation, may be required during deeper levels of sedation. The Classic laryngeal mask airway (LMA) is not MRI compatible, although the LMA proseal and supreme are MRI conditional for 1.5 Tesla or less.
During lighter levels of sedation when neurophysiological testing is required, such devices may not be tolerated by patients, and may need to be removed, as is the practice in sleep-awakesleep technique 9 .
The use of sedatives in awake craniotomies has been shown to cause higher PaCO 2 levels in patients as compared to those under general anaesthesia in whom ventilator settings determined the PaCO 2 . However this did not directly result in any adverse impact such as brain swelling when compared to patients undergoing general anaesthesia, nor did it result in more mannitol use or conversion to general anaesthesia 9 .
In order to titrate the level of sedation, infusions of sedative drugs with short context sensitive halflives such as propofol and remifentanil are commonly used in awake craniotomies. They can be manually controlled or administered via target-controlled infusions (TCI) based on pharmacokinetic models.
Infusions via a TCI system are useful for estimating effect-site concentrations to aid the control of the depth of anaesthesia according to clinical circumstances, and to predict awakening after prolonged infusions. One case study showed better correlation between the bispectral index (BIS) and the level of patient's responsiveness than using the predicted effect-site concentrations of propofol 12 .
Another case report reported significant correlation between BIS and predicted effect-site concentrations of propofol and remifentanil 13 . Ultimately it has been shown that various pharmacokinetic models have biases and their accuracy depends on choosing the best model for the right patient 14, 15 . Therefore, any TCI should be titrated according to patient's responsiveness.
There are no MRI-safe TCI pumps in our centre (such as the Alaris Asena® PK and Injectomat® Agilia), thereby explaining why we eschewed TCI use in this case 16 .
As discussed earlier, over-sedation can result in respiratory compromise. In this respect, dexmedetomidine is advantageous as it is noted to have few respiratory side effects 17 and has opioid sparing as well as anaesthesia sparing effects 18 .
Dexmedetomidine is a highly specific alpha-2 agonist that acts centrally to decrease sympathetic tone, with amelioration of the neuroendocrine and haemodynamic responses to anaesthesia and surgery. It reduces anaesthetic and opioid requirements by causing sedation and analgesia 19 . Fortuitously, it allows psychomotor function to be preserved while letting the patient rest comfortably 20 . Thus dexmedetomidine facilitates patient comfort and cooperation by offering sedation with the ability to rouse patients to timely communication with healthcare workers 21 .
Based on the manufacturer's guidelines, a loading dose of 1 mcg/kg of dexmedetomidine for 10 min followed by an infusion at 0.3 mcg/kg/hr produces a Ramsay Score of 4-5 within 20-25 min, while a loading dose of about 0.5 mcg/kg for 10 min followed by an infusion of 0.2 mcg/kg/hr produces a Ramsay Score of 3-4 within 15-30 min 22 . Due to potential side effects of hypotension and respiratory depression with concomitant use of remifentanil, we used a lower load of 0.3 mcg/kg.
Other sedatives and analgesics such as propofol, remifentanil and midazolam were used to augment the sedation with dexmedetomidine prior to 0.5% bupivacaine infiltration for scalp blocks and head pinning. As a result of the short acting nature of these additional sedatives, the patient was able to awaken sufficiently after dural opening and brain exposure to cooperate with functional testing. In this regard, dexmedetomidine is less flexible as full effects after each dosage adjustments could take up to 20-30 minutes to be achieved 22 . This may render intra-operative titration more challenging if dexmedetomidine was used as the sole sedative agent, and may lead to periods of undersedation or oversedation if there was inadequate communication between the surgeon and anaesthetist.
A study by Garavaglia et al. using dexmedetomidine as the primary sedative agent found that stopping dexmedetomidine 15 minutes before neurological testing allowed their patient's sedation to lighten adequately to facilitate neurological testing 23 .
During the more painful and stimulating parts of the surgery, additional opioids were needed to obtund the pain stimulus. We chose a continuous infusion of remifentanil in addition to dexmedetomidine as it has a fast onset and offset, thereby allowing rapid and easy titration of sedation depth and analgesia according to the stage of the surgery. Remifentanil also has advantages of organ-independent elimination and a consistent context sensitive half-life, which is useful in prolonged surgeries to prevent significant accumulation in tissues, which may result in delayed awakening at the end of surgery 24 .
A few cases of awake craniotomies have been done successfully with dexmedetomidine as the primary sedative agent, augmented with small amounts of opioids and benzodiazepines during the more painful parts of the surgery. Ard et al. adopted the sleep-awake-sleep technique, by inducing general anaesthesia at the beginning of surgery till dural exposure, than awakening patients and transitioning them to dexmedetomidine sedation for neurology testing, and then inducing general anaesthesia again for dural and skin closure. Their patients' airway was maintained with the LMA under general anaesthesia which was then removed when they woke the patient up for assessment. They found that patients emerged smoothly from anaesthesia with minimal coughing and disorientation. They reported no episodes of desaturation during dexmedetomidine sedation 25 .
In contrast, Garavaglia et al. conducted awake craniotomies with the awake-awake-awake technique by keeping their patients sedated on dexmedetomidine infusion, and adjusting the dose according to the level of surgical intensity and augmented with additional opioids and benzodiazepines when needed. Their patients did not require airway intervention during the awake portion 23 .
Dexmedetomidine has several advantages over propofol. A study of dexmedetomidine versus propofol or midazolam for sedation in the intensive care unit found that although there is no difference in time to target sedation between use of dexmedetomidine and propofol, patient interaction was significantly improved with dexmedetomidine 21 .
In a randomised, double blinded study that compared the use of dexmedetomidine and propofol for sedation during an awake craniotomy, dexmedetomidine was found by Shen et al.
to provide a shorter time to rousing for the patient and higher surgical satisfaction, although the quality of rousing process was similar 26 .
Dexmedetomidine has been shown to have synergistic effects with midazolam 27 , propofol 18 , opioids and benzodiazepines for sedation, which allows us to use lower doses of these agents.
Finally, dexmedetomidine has also been shown in craniotomies to attenuate the haemodynamic and neuroendocrinal response to skull pinning when given as a single dose before induction of anaesthesia 28 .
Dose-dependent bradycardia and decrease in blood pressure are the most common haemodynamic effects of dexmedetomidine and occur as a result of its agonistic effect on the a-2 adrenoreceptors 22 . Our patient did not demonstrate these haemodynamic changes despite variations in intensity of surgical stimulus and corresponding changes in sedation level. This may be attributed to appropriate depth of analgesia and sedation.
Dexmedetomidine has a terminal half-life of about two hours 22 . It has been demonstrated to be effective in reducing post-operative pain scores, opioid consumption and post-operative nausea and vomiting compared to general anaesthesia for craniotomies 9 .
Pharmacodynamically, dexmedetomidine has been shown to reduce cerebral blood flow, which can counter the rise in cerebral blood flow secondary to hypercarbia 29 .
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Seizures can be minimised with prophylactic anti-epileptic use. When seizures occur intraoperatively, it is managed by stopping surgery and irrigating the brain surface with cold saline, and/or administering low-dose propofol or midazolam 9 .
Finally, to avoid intra-operative and post-operative retching and vomiting, we gave our patient three different classes of anti-emetics before the start of the surgery. A retching and vomiting patient with head tightly pinned and an exposed brain could result in scalp and muscle tears from the pins, aspiration and even brain herniation. Nausea can also affect patient's cooperation during the surgery.
Post-operative vomiting also leads to undesirable rises in intracranial pressure.
Awake craniotomy should ideally be done on uncomplicated tumours which are discrete and superficial, and therefore of short duration (ideally below three hours). When intra-operative MRI scanning is incorporated, much time is spent on preparing the patient for MRI scanning, especially if repeated scans are done to evaluate completeness of resection. Our patient underwent a total of four intra-operative MRI scans. Since each scan would take at least 15 min, this adds up to at least an hour of overall anaesthesia time, which is significant, since the entire procedure took six hours. The long duration may also mean that the initial scalp blocks infiltrated before the start of the surgery may wear off before the end of the surgery, requiring repeat blocks. Fortunately for our patient, no additional local anaesthetic infiltration was required for the pin sites.
Prolonged scanning in MRI adds to the patient discomfort because of the need to be still, noise and longer scanning time. During scanning, the patient's sedation was also lightened since the anaesthetists were not in the room with her. Hence, patient positioning is crucial to avoid intraoperative discomfort 32 . As the ambient operating room temperature may be too cold for patients, the use of forced air warming blanket and temperature monitoring to keep the patient normothermic will improve her tolerance of the procedure.
Our patient was motivated and engaging, and had no major neurological deficits pre-operatively or comorbidities. Hence she was a good candidate for the procedure.
Many studies have shown awake craniotomies to be well accepted amongst patients 31, 32 although it is prudent to assess each patient's suitability. Firstly, there must be no patient contraindication to using iMRI eg. presence of cardiovascular implantable electronic devices. Secondly, evaluation of the pre-operative intra-cranial pressure is also crucial, because intracranial pressure control during spontaneous breathing is much harder compared to mechanical ventilation.
The presence of major neurological deficits is a contraindication for awake craniotomy since they preclude effective neurological testing. For example, pronounced aphasia precludes speech testing. As for motor testing, as long as enough residual movement to be tested is preserved, there is no contraindication. Some centres use the Mini-Mental State Examination and language tests preoperatively to screen their patients for suitability for awake craniotomy -those demonstrating tendency towards uncooperative behaviour, e.g. inhibited, apathetic and disorganised behaviour patterns, should be excluded 31 .
Patients with unstable medical conditions and/ or difficult airway that preclude safe sedation will require careful balancing of the risks of awake craniotomy versus the benefits of such procedure. Preoperative airway evaluation is essential given the difficulty of managing airway complications and the possibility of obstruction during the surgical procedure. Mallampati score and other predictors of difficult intubation and any history of previous anaesthesia must be carefully reviewed.
Patients with comorbidities such as morbid obesity, history of obstructive sleep apnoea (OSA) and active gastroesophageal reflux disease (GERD) may not be suitable for awake craniotomy 25 . A BMI higher than 30 has been found to be a consistent risk factor for desaturation, requiring a secured airway in one review of 332 propofol based awake craniotomies 33 as arterial hypertension, ischaemic heart disease, atrial fibrillation and stroke and hence is often a major contraindication to awake craniotomy 34 .
Interestingly, a regimen of dexmedetomidine and scalp block, augmented with opioids and midazolam, has been used in a select group of high risk patients with a motley of conditions such as chronic obstructive pulmonary disease, GERD, anxiety, panic disorders, midline shift and seizures. The authors were able to carry out the surgery without airway interventions nor adverse events 23 .
Patients should be given advance information about the rationale and technique of surgery to improve compliance. An adequate preoperative explanation about potential risks, stages of procedure, and sequence of events in operating theatre improves patients' tolerance 35 .
CONCLUSIONS
We describe a novel, previously unreported locally, but successful technique of sedation for awake craniotomy (a highly challenging surgical procedure) performed in a hostile iMRI environment, interrupted for several MRI scanning.
Twin infusions of remifentanil and dexmedetomidine titrated to stimulation and neurophysiological testing, is a good technique for patients undergoing awake craniotomy due to the synergy between the ease of titration of remifentanil and the favourable pharmacodynamics of dexmedetomidine.
This was augmented with scalp blocks and aliquots of midazolam and propfol at appropriate times as dexmedetomidine is known to cause less rapid change in depth of sedation during dosing changes. The unique features of dexmedetomidine that allows quick rousing and alertness are eminently useful for awake craniotomy.
The success of this procedure depends on careful patient selection, familiarity with the sedation technique, as well as surgical factors such as experienced surgeons.
